Optimi Health's new distribution agreement with Vitasave provides retail access to two of Canada's largest urban markets.
Optimi Health's new distribution agreement with Vitasave provides retail access to two of Canada's largest urban markets.
After just uplisting to the TSX in Canada, Field Trip Health has applied to uplist to the NASDAQ in the U.S.
Psychedelic drugs increasingly appear to be powerful medicinal tools to rebuild broken brains.
Field Trip Health has uplisted to the TSX in Canada.
A Psychedelic Drug Revolution is underway to address the Mental Health Crisis. As with all revolutions, we are seeing a rapid shift in attitudes.
Novamind's clinic revenues jumped 43% quarter-over-quarter, to CAD$1.85 million. Projecting a 225% increase in clinic visits year-over-year.
The psychedelic drug industry already has a large footprint in healthcare. And it is growing in literally every direction.
Mydecine receives regulatory approval to expand its psilocybin mushroom cultivation operations.
MindMed executes an MOU to access the drug delivery system of Israel-based Nextage Therapeutics.
NASDAQ-listed Enveric Biosciences is merging with private psychedelics company, Magic Med Industries.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now